Astra Zeneca Tops Indian Pharma in New Introductions 2024

Analysis of Indian Pharmaceutical Market (IPM) – 2024

This data provides insights into the top new introductions (NI) in the Indian Pharmaceutical Market (IPM) for the last 12 months (Dec 2023 - Dec 2024).

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Astra Zeneca Tops Indian Pharma in New Introductions 2024

Free Membership Required

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Anuj Pasrija Elevated to Country Lead, J&J MedTech India and Vice President – Surgery

China’s Biopharma Strategy: A Warning and Opportunity for India

Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.

Who Is Accountable for the Medicine in Your Hand?

Topics

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Anuj Pasrija Elevated to Country Lead, J&J MedTech India and Vice President – Surgery

China’s Biopharma Strategy: A Warning and Opportunity for India

Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.

Who Is Accountable for the Medicine in Your Hand?

Who Profits From Trust?

The Great Healthcare Dilemma: Who Will Own the Next Indian Hospital?

Indian Pharma’s Three Deficits—and Three Potential Dividends

Related Articles

Biocon Bats for Affordable Insulin and Ozempic

Vivek V. Kamath Appointed CEO at PlasmaGen BioSciences

Is Your Field Force Optimised to Make the Most of Market Growth in Metros?

Astra Zeneca Tops Indian Pharma in New Introductions 2024

IQVIA Sponsors Race for 7 to Commemorate World Rare Disease Day

Company

Headlines

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Anuj Pasrija Elevated to Country Lead, J&J MedTech India and Vice President – Surgery

China’s Biopharma Strategy: A Warning and Opportunity for India

Chirag Mehta has been appointed as Executive Director at ERIS Lifesciences.

Newsletter